Delivery Order SPE2DB24D9105-SPE2DB25FBYVY
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $11,353.77 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Lenvima 8 mg daily dose (60-count). The award, issued on September 23, 2025, with an ultimate completion date of October 15, 2025, represents a firm fixed-price delivery order with no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $11,353.77 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Lenvima 14 mg daily dose medication (60-count supply). This firm fixed-price delivery order, issued on September 11, 2025, with an ultimate completion date of October 2, 2025, represents a tactical fulfillment under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a delivery order valued at $11,353.77 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Lenvima 12 mg daily dose in 90-count quantities. The award, issued on August 7, 2025, with an ultimate completion date of August 28, 2025, utilizes firm fixed-price terms without a set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $11,353.77 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for LENVIMA 20 MG daily dose medication (60-count supply). The contract was awarded on September 29, 2025, with an ultimate completion date of October 21, 2025, and does not utilize a set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's existing...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $22,707.56 to DMS Pharmaceutical Group Inc. for the supply of LENVIMA 10 mg daily dose (30-count) medication. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without set-aside designation. The delivery order is scheduled for completion by September 22, 2025, and represents a discrete fulfillment under the company's broader...
- The U.S. Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. for LENVIMA 20 mg daily dose (60-count supply) valued at $11,353.77 on August 21, 2025, with completion expected by September 12, 2025. This firm fixed-price delivery order was awarded without set-aside designation to the Park Ridge, Illinois-based woman-owned small business pharmaceutical wholesaler. The award is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency (DLA) on September 17, 2025, for LENVIMA 8 mg daily dose medication (60-count supply). The contract is valued at $29,624.58 and operates under a firm fixed-price delivery order structure with an ultimate completion date of October 8, 2025. This award carries no set-aside designation, allowing DMS Pharmaceutical Group...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,353.77 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Lenvima 18 mg daily dose medication in a 90-day supply. The contract, issued on September 8, 2025, with an ultimate completion date of September 29, 2025, operates under a firm fixed-price structure with no set-aside designation. This delivery order is issued under DMS...
- The Defense Logistics Agency awarded a delivery order valued at $11,353.77 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Lenvima 10 mg daily dose tablets (30-count packaging). This firm fixed-price delivery order was issued on September 10, 2025, with an ultimate completion date of October 1, 2025, and carries no set-aside designation. DMS Pharmaceutical Group is performing this work from its Park Ridge...
- The Defense Logistics Agency awarded a $11,353.77 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. on September 18, 2025, for the supply of Lenvima 20 mg daily dose (60-count packages). DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work at its Park Ridge location with an ultimate completion date of October 9, 2025. The contract carries no set-aside designation, allowing the vendor to compete...
- SPE2DB24D9105Indefinite Delivery Contract
- SPE2DB24D9105-SPE2DB25FBYVYDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $11,286.98 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of LENVIMA 8 mg daily dose medication in 60-count units. The delivery order, issued on September 29, 2025, with an ultimate completion date of October 21, 2025, operates under a firm fixed-price contract type with no set-aside designation. This award is issued as a delivery order under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 and valid through November 2026, which enables the agency to procure a comprehensive range of pharmaceutical products supporting military healthcare facilities nationwide. DMS Pharmaceutical Group leverages its established position as a critical supplier in the federal pharmaceutical supply chain to fulfill the Defense Logistics Agency's medication procurement requirements. The company's core business involves distributing branded and generic prescription drugs, biologics, and medical consumables to Department of Defense healthcare systems, with a proven track record of executing delivery orders for specialized pharmaceutical products including oncology treatments and other prescription medications. This delivery order for LENVIMA, an oncology medication, exemplifies the company's ongoing support of military medical supply operations across the federal healthcare system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.3k | 9/29/25 |